Mercy Ofuya and Professor Janet Peacock contribute to the promising results of the EBSTEM trial

MedStats team members, Mercy Ofuya (PhD student) and Professor Janet Peacock have been the Statisticians in the Phase I/II EBSTEEM trial of a ‘new stem-cell therapy for a rare and debilitating skin condition…’ The outcomes of the trial, which assessed reduction in severity of the disease and quality of life in patients, found promising results. http://www.kcl.ac.uk/newsevents/news/newsrecords/2015/May/Stem-cell-therapy-for-inherited-skin-blistering.aspx

Advertisements